NY Decries 'Brazen Gaslighting' By Endo's Opioid Attys
By Jeff Overley (August 19, 2021, 11:05 PM EDT) -- The New York Attorney General's Office on Thursday declared that belated and begrudging disclosures by Endo Pharmaceuticals in a tumultuous opioid trial contain "case-changing" revelations and fresh evidence of misconduct by the drugmaker's lawyers.
In a 30-page filing, the office announced that it has found a dozen "directly relevant, highly inculpatory" sets of records since Aug. 1, when it first accused Endo of egregious discovery misconduct necessitating a default liability judgment in the ongoing trial.
Those records — some of which were described during recent oral arguments on the default judgment bid and other trial proceedings — allegedly include an email...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!